Literature DB >> 29157394

New Insights into Multiple Sclerosis Clinical Course from the Topographical Model and Functional Reserve.

Stephen C Krieger1, James Sumowski2.   

Abstract

Clinical course in multiple sclerosis (MS) is difficult to predict on group and individual levels. We discuss the topographical model of MS as a new approach to characterizing the clinical course, with the potential to personalize disability progression based on each individual patient's pattern of disease burden (eg, lesion location) and reserve. The dynamic clinical threshold depicted in this visual model may help clinicians to educate patients about clinical phenotype and disease burden, and foster an understanding of the difference between relapses and pseudoexacerbations. There is an emphasis on building reserve against cognitive and physical decline, encouraging agency among patients.
Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clinical course; Multiple sclerosis; Prognosis; Reserve; Topographical model

Mesh:

Year:  2017        PMID: 29157394     DOI: 10.1016/j.ncl.2017.08.003

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  5 in total

1.  Clinically Assessed Walking Capacity Versus Real-World Walking Performance in People with Multiple Sclerosis.

Authors:  Kedar K V Mate; Nancy E Mayo
Journal:  Int J MS Care       Date:  2020-06-15

2.  Functional and self-care capacity of people with multiple sclerosis.

Authors:  Ana Railka de Souza Oliveira-Kumakura; Larissa Maria Bezutti; Juliany Lino Gomes Silva; Renata Cristina Gasparino
Journal:  Rev Lat Am Enfermagem       Date:  2019-10-07

Review 3.  Central nervous system macrophages in progressive multiple sclerosis: relationship to neurodegeneration and therapeutics.

Authors:  Emily Kamma; Wendy Lasisi; Cole Libner; Huah Shin Ng; Jason R Plemel
Journal:  J Neuroinflammation       Date:  2022-02-10       Impact factor: 8.322

4.  Unmet Needs and Treatment of Relapsing-Remitting Multiple Sclerosis in Saudi Arabia: Focus on the Role of Ofatumumab.

Authors:  Matthew Craner; Yaser Al Malik; Fawzi A Babtain; Foziah Alshamrani; Mona M Alkhawajah; Nora Alfugham; Rumaiza H Al-Yafeai; Salman Aljarallah; Seraj Makkawi; Shireen Qureshi; Marina Ziehn; Hazem Wahba
Journal:  Neurol Ther       Date:  2022-09-01

5.  The topographical model of MS: Empirical evaluation of the recapitulation hypothesis.

Authors:  Benjamin M Laitman; Karin Cook; Madhuri Fletcher; Stephen C Krieger
Journal:  Mult Scler J Exp Transl Clin       Date:  2018-10-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.